Leap Therapeutics Inc. buy Mizuho
Start price
17.04.23
/
50%
€3.36
Target price
17.04.24
€18.32
Performance (%)
-19.05%
End price
18.04.24
€2.72
Summary
This prediction ended on 18.04.24 with a price of €2.72. The price of Leap Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.05%. Mizuho has a follow-up prediction for Leap Therapeutics Inc. where he still thinks Leap Therapeutics Inc. is a Buy. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | 12.879% | 12.879% | -17.222% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
Comments by Mizuho for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $2.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
In the thread Trading Leap Therapeutics Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten
Current prediction by Mizuho for Leap Therapeutics Inc.
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.88
20.11.23
20.11.23
€10.97
20.11.24
20.11.24
58.51%
25.04.24
25.04.24
Stopped prediction by Mizuho for Leap Therapeutics Inc.
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.64
17.03.23
17.03.23
€18.80
17.03.24
17.03.24
-42.79%
18.03.24
18.03.24